
Dr. Ravikumar Ramegowda
Co-founder, President & CTO
Co-founded SusMer in 2014. His work in monomers, catalysts and ring-opening polymerization connects polymer chemistry with material and process development.
P4HB biomaterials for medical devices
SusMerFlex™ — chemically synthesized P4HB
for medical-device manufacturers.
The material. The method.
SusMerFlex™ is SusMer’s P4HB raw material, produced through ring-opening polymerization. It offers a chemical synthesis route to a polymer already used in absorbable sutures and hernia meshes.
Our development work brings together molecular-weight selection, material characterization and process scale-up. We work with device manufacturers to evaluate the material against their application and processing requirements.
Start a technical conversationMedical-device applications
Sutures and hernia meshes put P4HB to work in soft-tissue repair. SusMer focuses on the raw material and the requirements of the manufacturers building those devices.
These 3D studies illustrate established P4HB device categories. They are not SusMer products or validated device designs; finished devices require their own testing and authorization.
B. Braun: Monomax® P4HB monofilament sutures ↗BD: Phasix™ P4HB hernia mesh ↗
These products provide material-class context. Their clinical evidence and regulatory status do not apply to SusMerFlex™.
The people behind SusMer
Founded to commercialize chemistry developed at Colorado State University, SusMer brings scientists and industry operators together in Fort Collins, Colorado.

Co-founder, President & CTO
Co-founded SusMer in 2014. His work in monomers, catalysts and ring-opening polymerization connects polymer chemistry with material and process development.

Co-founder & Scientific Advisor
University Distinguished Professor at Colorado State University. His research in polymer chemistry forms the scientific foundation of SusMer’s approach.

Chief Executive Officer
Brings more than 20 years of medical-device commercial and corporate development experience, with past roles at Johnson & Johnson, Confluent Medical and Heraeus Medical.

Chief Financial & Operating Officer
Joined SusMer in 2019. Leads finance and operations, supporting commercialization and relationships with medical-device manufacturers and development partners.
Work with SusMer
We work with medical-device OEMs, contract manufacturers and research partners to define the material evaluation and development work an application needs.
Share your device category, processing route, material form and target properties.
Discuss available grades, sample quantities and the testing needed to assess fit.
Align on characterization, process development and scale-up priorities.
Before we begin
SusMerFlex™ is SusMer’s chemically synthesized P4HB raw material for medical-device development. It is a material platform, not a finished suture or surgical mesh.
SusMer uses ring-opening polymerization as an alternative to microbial fermentation. Development work focuses on molecular-weight selection, material characterization and manufacturing scale-up.
Pellets and films are the starting material formats. Contact the team to confirm current grades, evaluation quantities and timing for your program.
Start with the intended application and processing route. The team can discuss a material evaluation plan and available characterization information. Suitability, processing compatibility and biological safety need to be assessed for the specific finished device.
For OEMs, CMOs & CDMOs
Discuss SusMerFlex™ for your device,
your process and your development timeline.
contact@susmer.com